CEF12 is an EBV-derived peptide containing residues 399-408 from NA3B, supporting T-cell epitope mapping and viral-sequence motif analysis. Its structure enables studies of β-turn formation and residue accessibility. Researchers assess conformational states to identify conserved antigenic determinants. The peptide aids comparative viral-epitope investigations.
CAT No: C14012
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More